Security key
M96088105
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 523,530
- Total 13F value
- $19,279,357
- Share change
- +76,095
- SEC-reported price per share
- $36.80
- Number of holders
- 25
- Value change
- +$3,892,597
- Number of buys
- 11
- Number of sells
- 10
- Shares outstanding
- 48,684,257
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
25
Top holders
10
URGN full security history
Ownership snapshot
Full 13F holder table
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Ownership snapshot
Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TORONTO DOMINION BANK
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 5.4%
13D/G row: TORONTO DOMINION BANK
Showing 1-6 of 15 holder rows.
Quick read
TORONTO DOMINION BANK leads the comparable SEC ownership view at 5.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TORONTO DOMINION BANK's linked filing trail.
Comparable ownership
Top 5
TORONTO DOMINION BANK
5.4%
MORGAN STANLEY
5.4%
BlackRock, Inc.
5.2%
MENORA MIVTACHIM HOLDINGS LTD.
5%
Soleus Capital Master Fund, L.P.
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TORONTO DOMINION BANK |
13D/G
13F
The Toronto-Dominion Bank · Company
|
5.4%
|
$53,066,960
2,616,714 shares
|
+$6,375,626 | 31 Mar 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$46,029,492
2,560,038 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.2%
from 13D/G
|
$51,163,295
2,845,567 shares
|
— | 31 Mar 2026 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13D/G
13F
Company
|
5%
|
$24,780,614
2,303,031 shares
|
$0 | 11 Mar 2025 |
| Soleus Capital Master Fund, L.P. |
13D/G
|
4.7%
|
$31,114,400
2,185,000 shares
|
-$1,993,600 | 30 Jun 2025 |
| Paradigm Biocapital Advisors LP |
13D/G
13F
Company
|
3.5%
|
$34,556,086
1,703,949 shares
|
-$50,946,098 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
523,530
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
172
Q2 2026 holders
25
Holder diff
-147
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend